Rankings
▼
Calendar
VCEL Q4 2017 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena
VCEL
Vericel Corporation
$2B
Q4 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$23M
+41.3% YoY
Gross Profit
$15M
64.1% margin
Operating Income
$1M
5.1% margin
Net Income
$287,000
1.2% margin
EPS (Diluted)
$0.01
QoQ Revenue Growth
+63.7%
Cash Flow
Operating Cash Flow
$834,000
Free Cash Flow
$116,000
Stock-Based Comp.
$627,000
Balance Sheet
Total Assets
$55M
Total Liabilities
$32M
Stockholders' Equity
$23M
Cash & Equivalents
$27M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$23M
$17M
+41.3%
Gross Profit
$15M
$9M
+67.5%
Operating Income
$1M
-$6M
+120.2%
Net Income
$287,000
-$6M
+104.6%
← FY 2017
All Quarters
Q1 2018 →